Product Images Argatroban
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Argatroban NDC 67457-212 by Mylan Institutional Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Argatroban Injection 250 mg/2.5 mL Carton Label - image 01
Figure 1: Relationship at Steady-State Between Argatroban Dose, Plasma Argatroban Concentration and Anticoagulant Effect - image 02
This is a chart that shows the results of a test for W aPTT in seconds (sec) and the plasma concentration of Argatroban in micrograms per milliliter (mcg/mL). There are also measurements for infusion dose in meg/kg/min. The chart seems to be related to a 19-year-old patient.*
Figure 2: INR Relationship of Argatroban Plus Warfarin Versus Warfarin Alone - image 03
Figure 3: Time to First Event for the Composite Efficacy Endpoint: HIT Patients - image 04
This text is a table showing the results of a study with two groups of participants, one receiving Aralroban and another serving as the Historical Control. The table presents the number of participants in each group as well as the p-value obtained from the study. The "censored" column indicates that no clinical endpoint was observed during the follow-up period, which was a maximum of 37 days.*
Figure 4: Time to First Event for the Composite Efficacy Endpoint: HITTS Patients - image 05
This study, referred to as "STUDY 1", compared the effectiveness of Argatroban (administered to 144 participants, with 81 being censored) to a historical control group (consisting of 46 individuals, with 20% being censored). The study day was measured at 21, 28, and 35 days. The term "censored" indicates that no clinical endpoint (such as death, amputation, or new thrombosis) was observed during the follow-up period, which had a maximum duration of 37 days. A p-value of 0.018 was obtained suggesting a statistically significant difference between the two groups.*
Argatroban Structural Formula - image 06
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.